The overall objective is for the preparation of bulk chemicals/drugs that are needed by the NExT and other programs. The required materials are not readily available in the quality or quantities needed from the original supplier or on the open market. Major aspects of the contract work scope will include: (1) GMP process development to transform a laboratory scale to larger scale production;(2) synthesis of bulk chemicals/drugs on multi-grams to multi-kilograms scale as needed;(3) analysis for ensuring the purity, identity and quality of the prepared compounds including QA/QC for the GMP batches;and (4) additional studies such as solubility/stability when required. Technical reports submitted by the Contractors may be used to support IND applications to the FDA.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource and Support Contracts (N02)
Project #
261201100101C-0-0-1
Application #
8353111
Study Section
Project Start
2011-09-20
Project End
2012-09-19
Budget Start
Budget End
Support Year
Fiscal Year
2011
Total Cost
$515,467
Indirect Cost
Name
Starks Associates, Inc.
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14213